Apple Watch Risks US Import Ban After Biden Administration Upholds Patent Ruling
The Biden administration has declined to overrule a U.S. International Trade Commission decision that the Apple Watch infringes patents from medical device company AliveCor, potentially paving the way for an import ban on Apple's smartwatch depending on how the appeals process pans out.

California-based AliveCor said in a statement that it was informed the Biden administration would not overrule a December decision from the ITC that found the Apple Watch infringed AliveCor health monitoring patents related to electrocardiogram technology. From AliveCor's press release:
"We applaud President Biden for upholding the ITC's ruling and holding Apple accountable for infringing the patents that underpin our industry-leading ECG technology," said Priya Abani, CEO of AliveCor. "This decision goes beyond AliveCor and sends a clear message to innovators that the U.S. will protect patents to build and scale new technologies that benefit consumers."
In the December ruling, the ITC recommended a limited exclusion order and a cease-and-desist order for Apple Watch models with ECG features. Were it to be enforced, Apple would no longer be able to import new Apple Watch models that support the ECG app. Apple plans to appeal the ITC's decision in a federal courthouse.
While the ITC decision could end up in an Apple Watch ban, the US Patent and Trademark Office in December also invalidated some of AliveCor's patents, which the medical tech company says it will appeal. At the time, Apple said the ITC's decision confirms that the patents AliveCor asserted in the ITC against Apple cannot be infringed.
AliveCor and Apple are embroiled in several legal battles, as AliveCor has also filed an antitrust lawsuit against Apple and Apple has sued AliveCor for patent infringement. Apple is also battling a patent infringement case brought by medical technology company Masimo, which asserts Apple Watch models that use light sensors to measure blood oxygen levels infringe its pulse oximeter patents.
Popular Stories
Bloomberg's Mark Gurman has high expectations for Apple's first foldable iPhone.
In his Power On newsletter today, he said the foldable iPhone will be "the most significant overhaul in the iPhone's history."
"iPhone 4, iPhone 6 and iPhone X were clearly a big deal, but this is a whole new design," he said.
Like Samsung's Galaxy Z Fold 7, the foldable iPhone will reportedly open up like ...
iOS 26.5 is now available for developers, and while it doesn't include any new Siri capabilities, there are some major changes for the European Union, and smaller tweaks for features available worldwide.
Suggested Places
In the Maps app, there's a new "Suggested Places" feature that recommends locations to visit based on trending places nearby and recent searches. When Apple launches ads in ...
Apple has been celebrating its upcoming 50th anniversary by hosting surprise performances and other events around the world over the past few weeks, and now Bloomberg's Mark Gurman has revealed details about the company's grand finale.
In a social media post, Gurman said Apple's celebrations will conclude this week with a finale at its Apple Park headquarters for employees.
A special...
Popular Stories
Apple is hoping to 3D-print aluminum device enclosures in the future, according to Bloomberg's Mark Gurman.
In today's "Power On" newsletter, Gurman revealed that Apple is pushing to move to 3D-printed aluminum enclosures for for future devices. The MacBook Neo relies on a new aluminum manufacturing process that saves as much metal as possible to drive down costs and speed up production....
Apple today launched its atrial fibrillation history feature for Apple Watch in mainland China.
Since 2022, Apple Watch in the U.S. has supported AFib History, which allows users diagnosed with atrial fibrillation to view an estimate of how frequently their heart is in this type of irregular rhythm.
The feature analyzes pulse rate data collected by a photoplethysmography (PPG) sensor to...
Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge said this week (via Reuters).
After Apple was found to have violated Masimo's patents related to blood oxygen sensing, the Apple Watch faced a U.S. import ban that caused Apple to briefly pause...